Diabetes may not blunt spironolactone’s benefits in frail HFpEF patients
A secondary analysis of the TOPCAT trial found spironolactone associated with lower death and hospitalization risks in frail HFpEF patients, ...
A secondary analysis of the TOPCAT trial found spironolactone associated with lower death and hospitalization risks in frail HFpEF patients, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.